It seems that sex selection makes its way into headlines as frequently as stem cell research nowadays. In many countries, particularly in Asia, the issue is in the political forefront. In the US it makes it as far as the media but still remains on the backburner in the policy and political worlds. Pre-implantation Genetic Diagnosis (PGD), one of the technologies used to perform sex selection is offered widely in the US. For now, there are only guidelines set by the American Society for Reproductive Medicine (ASRM) for non-medical uses of PGD, though clinics around the country are allowing parents to choose the sex of their child anyway. The stories about Indian immigrants in the US taking advantage of this troubling technology are particularly interesting. Check out what Sujatha Jesudason (CGS program director) has to say about this on an "All Things Considered" series on NPR.
Related: In India this week, a debate was underway about what impact sex selection has had on the country's female population.
By Abby McCloskey, The Dallas Morning News | 10.10.2025
Aggregated News
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Jay S. Kaufman, Los Angeles Review of Books | 09.27.2025
Aggregated News
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...
By Julia Black, MIT Technology Review | 10.16.2025
Aggregated News
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.